Compare IRTC & ASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRTC | ASH |
|---|---|---|
| Founded | 2006 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Specialty Chemicals |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.1B |
| IPO Year | 2016 | 2016 |
| Metric | IRTC | ASH |
|---|---|---|
| Price | $111.46 | $67.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 7 |
| Target Price | ★ $197.92 | $65.57 |
| AVG Volume (30 Days) | 620.1K | ★ 846.9K |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 3.38% |
| EPS Growth | ★ 61.71 | N/A |
| EPS | N/A | ★ 0.08 |
| Revenue | $747,138,000.00 | ★ $1,824,000,000.00 |
| Revenue This Year | $19.60 | $2.58 |
| Revenue Next Year | $15.94 | $4.28 |
| P/E Ratio | ★ N/A | $846.25 |
| Revenue Growth | ★ 26.24 | N/A |
| 52 Week Low | $100.85 | $46.30 |
| 52 Week High | $210.01 | $69.64 |
| Indicator | IRTC | ASH |
|---|---|---|
| Relative Strength Index (RSI) | 43.55 | 59.68 |
| Support Level | $111.37 | $58.70 |
| Resistance Level | $121.88 | $67.71 |
| Average True Range (ATR) | 5.67 | 1.77 |
| MACD | -1.16 | -0.02 |
| Stochastic Oscillator | 14.54 | 70.75 |
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
Ashland Inc. is a specialty materials company serving markets including pharmaceuticals, personal care, food and beverages, coatings, construction, energy, and electronics. It operates through four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences contributes the highest revenue, offering functional additives for pharmaceutical and nutrition applications. Personal Care provides ingredients for skin, hair, oral care, and household products, while Specialty Additives supplies performance-enhancing additives for coatings and. Intermediates produce BDO and related derivatives used in polymers, electronics, agriculture, and pharmaceutical applications. The company generates sales across North America, Europe, Asia Pacific, Latin America, and regions.